Mitochondrial Ca2+ remodeling is a prime factor in oncogenic behavior

Frontiers in Oncology

Volumn 5, Issue JUN, 2015, Pages

  Rimessi, Alessandro ^a   Patergnani, Simone ^a   Bonora, Massimo ^a   Wieckowski, Mariusz R ^b   Pinton, Paolo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

Ca2+ signaling; Cancer; Mitochondrial dysfunction; Oncogene and oncosuppressor

Indexed keywords

EID: 84934282828     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2015.00143     Document Type: Article

References (115)

1. Tarasov AI, Griffiths EJ, Rutter GA. Regulation of ATP production by mitochondrial Ca(2+). Cell Calcium (2012) 52:28-35. doi: 10.1016/j.ceca.2012.03.003.
2. Rizzuto R, Marchi S, Bonora M, Aguiari P, Bononi A, De Stefani D, et al. Ca(2+) transfer from the ER to mitochondria: when, how and why. Biochim Biophys Acta (2009) 1787:1342-51. doi:10.1016/j.bbabio.2009.03.015.
3. Scharwey M, Tatsuta T, Langer T. Mitochondrial lipid transport at a glance. J Cell Sci (2013) 126:5317-23. doi:10.1242/jcs.134130.
4. Sullivan LB, Chandel NS. Mitochondrial reactive oxygen species and cancer. Cancer Metab (2014) 2:17. doi:10.1186/2049-3002-2-17.
5. Rimessi A, Bezzerri V, Patergnani S, Marchi S, Cabrini G, Pinton P. Mitochondrial Ca(2+)-dependent NLRP3 activation exacerbates the Pseudomonas aeruginosa-driven inflammatory response in cystic fibrosis. Nat Commun (2015) 6:6201. doi:10.1038/ncomms7201.
6. Giorgi C, Baldassari F, Bononi A, Bonora M, De Marchi E, Marchi S, et al. Mitochondrial Ca(2+) and apoptosis. Cell Calcium (2012) 52:36-43. doi:10.1016/j.ceca.2012.02.008.
7. Rimessi A, Giorgi C, Pinton P, Rizzuto R. The versatility of mitochondrial calcium signals: from stimulation of cell metabolism to induction of cell death. Biochim Biophys Acta (2008) 1777:808-16. doi:10.1016/j.bbabio.2008.05.449.
8. Rizzuto R, Pinton P, Carrington W, Fay FS, Fogarty KE, Lifshitz LM, et al. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science (1998) 280:1763-6. doi:10.1126/science.280.5370.1763.
9. Baughman JM, Perocchi F, Girgis HS, Plovanich M, Belcher-Timme CA, Sancak Y, et al. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature (2011) 476:341-5. doi:10.1038/nature10234.
10. De Stefani D, Raffaello A, Teardo E, Szabo I, Rizzuto R. A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature (2011) 476:336-40. doi:10.1038/nature10230.
11. Schapira AH. Mitochondrial disease. Lancet (2006) 368:70-82. doi:10.1016/S0140-6736(06)68970-8.
12. Giorgi C, Agnoletto C, Bononi A, Bonora M, De Marchi E, Marchi S, et al. Mitochondrial calcium homeostasis as potential target for mitochondrial medicine. Mitochondrion (2012) 12:77-85. doi:10.1016/j.mito.2011.07.004.
13. Giorgi C, Missiroli S, Patergnani S, Duszynski J, Wieckowski MR, Pinton P. Mitochondria-associated membranes: composition, molecular mechanisms, and physiopathological implications. Antioxid Redox Signal (2015) 22:995-1019. doi:10.1089/ars.2014.6223.
14. Ivanova H, Vervliet T, Missiaen L, Parys JB, De Smedt H, Bultynck G. Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival. Biochim Biophys Acta (2014) 1843:2164-83. doi:10.1016/j.bbamcr.2014.03.007.
15. Messina A, Reina S, Guarino F, De Pinto V. VDAC isoforms in mammals. Biochim Biophys Acta (2012) 1818:1466-76. doi:10.1016/j.bbamem.2011.10.005.
16. Sancak Y, Markhard AL, Kitami T, Kovacs-Bogdan E, Kamer KJ, Udeshi ND, et al. EMRE is an essential component of the mitochondrial calcium uniporter complex. Science (2013) 342:1379-82. doi:10.1126/science.1242993.
17. Raffaello A, De Stefani D, Sabbadin D, Teardo E, Merli G, Picard A, et al. The mitochondrial calcium uniporter is a multimer that can include a dominant-negative pore-forming subunit. EMBO J (2013) 32:2362-76. doi:10.1038/emboj.2013.157.
18. Plovanich M, Bogorad RL, Sancak Y, Kamer KJ, Strittmatter L, Li AA, et al. MICU2, a paralog of MICU1, resides within the mitochondrial uniporter complex to regulate calcium handling. PLoS One (2013) 8:e55785. doi:10.1371/journal.pone.0055785.
19. Kamer KJ, Mootha VK. MICU1 and MICU2 play nonredundant roles in the regulation of the mitochondrial calcium uniporter. EMBO Rep (2014) 15:299-307. doi:10.1002/embr.201337946.
20. Patron M, Checchetto V, Raffaello A, Teardo E, Vecellio Reane D, Mantoan M, et al. MICU1 and MICU2 finely tune the mitochondrial Ca2+ uniporter by exerting opposite effects on MCU activity. Mol Cell (2014) 53:726-37. doi:10.1016/j.molcel.2014.01.013.
21. Palty R, Silverman WF, Hershfinkel M, Caporale T, Sensi SL, Parnis J, et al. NCLX is an essential component of mitochondrial Na+/Ca2+ exchange. Proc Natl Acad Sci U S A (2010) 107:436-41. doi:10.1073/pnas.0908099107.
22. Nicholls DG, Crompton M. Mitochondrial calcium transport. FEBS Lett (1980) 111:261-8. doi:10.1016/0014-5793(80)80806-4.
23. Jiang D, Zhao L, Clish CB, Clapham DE. Letm1, the mitochondrial Ca2+/H+ antiporter, is essential for normal glucose metabolism and alters brain function in Wolf-Hirschhorn syndrome. Proc Natl Acad Sci U S A (2013) 110:E2249-54. doi:10.1073/pnas.1308558110.
24. Bonora M, Bononi A, De Marchi E, Giorgi C, Lebiedzinska M, Marchi S, et al. Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition. Cell Cycle (2013) 12:674-83. doi:10.4161/cc.23599.
25. De Marchi E, Bonora M, Giorgi C, Pinton P. The mitochondrial permeability transition pore is a dispensable element for mitochondrial calcium efflux. Cell Calcium (2014) 56:1-13. doi:10.1016/j.ceca.2014.03.004.
26. Jouaville LS, Pinton P, Bastianutto C, Rutter GA, Rizzuto R. Regulation of mitochondrial ATP synthesis by calcium: evidence for a long-term metabolic priming. Proc Natl Acad Sci U S A (1999) 96:13807-12. doi:10.1073/pnas.96.24.13807.
27. Denton RM, Randle PJ, Martin BR. Stimulation by calcium ions of pyruvate dehydrogenase phosphate phosphatase. Biochem J (1972) 128:161-3.
28. McCormack JG, Halestrap AP, Denton RM. Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol Rev (1990) 70:391-425.
29. Bonora M, Patergnani S, Rimessi A, De Marchi E, Suski JM, Bononi A, et al. ATP synthesis and storage. Purinergic Signal (2012) 8:343-57. doi:10.1007/s11302-012-9305-8.
30. Kaplon J, Zheng L, Meissl K, Chaneton B, Selivanov VA, Mackay G, et al. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature (2013) 498:109-12. doi:10.1038/nature12154.
31. Cardenas C, Foskett JK. Mitochondrial Ca(2+) signals in autophagy. Cell Calcium (2012) 52:44-51. doi:10.1016/j.ceca.2012.03.001.
32. Tsunoda T, Koga H, Yokomizo A, Tatsugami K, Eto M, Inokuchi J, et al. Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines. Oncogene (2005) 24:1396-402. doi:10.1038/sj.onc.1208313.
33. Cardenas C, Miller RA, Smith I, Bui T, Molgo J, Muller M, et al. Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell (2010) 142:270-83. doi:10.1016/j.cell.2010.06.007.
34. Decuypere JP, Bultynck G, Parys JB. A dual role for Ca(2+) in autophagy regulation. Cell Calcium (2011) 50:242-50. doi:10.1016/j.ceca.2011.04.001.
35. Galluzzi L, Pietrocola F, Levine B, Kroemer G. Metabolic control of autophagy. Cell (2014) 159:1263-76. doi:10.1016/j.cell.2014.11.006.
36. Storr SJ, Carragher NO, Frame MC, Parr T, Martin SG. The calpain system and cancer. Nat Rev Cancer (2011) 11:364-74. doi:10.1038/nrc3050.
37. Racioppi L, Means AR. Calcium/calmodulin-dependent protein kinase kinase 2: roles in signaling and pathophysiology. J Biol Chem (2012) 287:31658-65. doi:10.1074/jbc.R112.356485.
38. Prevarskaya N, Skryma R, Shuba Y. Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer (2011) 11:609-18. doi:10.1038/nrc3105.
39. Amuthan G, Biswas G, Ananadatheerthavarada HK, Vijayasarathy C, Shephard HM, Avadhani NG. Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. Oncogene (2002) 21:7839-49. doi:10.1038/sj.onc.1205983.
40. Biswas G, Tang W, Sondheimer N, Guha M, Bansal S, Avadhani NG. A distinctive physiological role for IkappaBbeta in the propagation of mitochondrial respiratory stress signaling. J Biol Chem (2008) 283:12586-94. doi:10.1074/jbc.M710481200.
41. Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol (2005) 5:749-59. doi:10.1038/nri1703.
42. Zhao J, Zhang J, Yu M, Xie Y, Huang Y, Wolff DW, et al. Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene (2012) 32:4814-24. doi:10.1038/onc.2012.494.
43. Desai SP, Bhatia SN, Toner M, Irimia D. Mitochondrial localization and the persistent migration of epithelial cancer cells. Biophys J (2013) 104:2077-88. doi:10.1016/j.bpj.2013.03.025.
44. Campello S, Scorrano L. Mitochondrial shape changes: orchestrating cell pathophysiology. EMBO Rep (2010) 11:678-84. doi:10.1038/embor.2010.115.
45. Rimessi A, Bonora M, Marchi S, Patergnani S, Marobbio CM, Lasorsa FM, et al. Perturbed mitochondrial Ca2+ signals as causes or consequences of mitophagy induction. Autophagy (2013) 9:1677-86. doi:10.4161/auto.24795.
46. Ferrari D, Pinton P, Campanella M, Callegari MG, Pizzirani C, Rimessi A, et al. Functional and structural alterations in the endoplasmic reticulum and mitochondria during apoptosis triggered by C2-ceramide and CD95/APO-1/FAS receptor stimulation. Biochem Biophys Res Commun (2010) 391:575-81. doi:10.1016/j.bbrc.2009.11.101.
47. He H, Lam M, McCormick TS, Distelhorst CW. Maintenance of calcium homeostasis in the endoplasmic reticulum by Bcl-2. J Cell Biol (1997) 138:1219-28. doi:10.1083/jcb.138.6.1219.
48. Pinton P, Ferrari D, Rapizzi E, Di Virgilio F, Pozzan T, Rizzuto R. The Ca2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 action. EMBO J (2001) 20:2690-701. doi:10.1093/emboj/20.11.2690.
49. Rong YP, Barr P, Yee VC, Distelhorst CW. Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor. Biochim Biophys Acta (2009) 1793:971-8. doi:10.1016/j.bbamcr.2008.10.015.
50. Rong YP, Bultynck G, Aromolaran AS, Zhong F, Parys JB, De Smedt H, et al. The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor. Proc Natl Acad Sci U S A (2009) 106:14397-402. doi:10.1073/pnas.0907555106.
51. Arbel N, Shoshan-Barmatz V. Voltage-dependent anion channel 1-based peptides interact with Bcl-2 to prevent antiapoptotic activity. J Biol Chem (2010) 285:6053-62. doi:10.1074/jbc.M109.082990.
52. Chami M, Prandini A, Campanella M, Pinton P, Szabadkai G, Reed JC, et al. Bcl-2 and Bax exert opposing effects on Ca2+ signaling, which do not depend on their putative pore-forming region. J Biol Chem (2004) 279:54581-9. doi:10.1074/jbc.M409663200.
53. Rowland AA, Voeltz GK. Endoplasmic reticulum-mitochondria contacts: function of the junction. Nat Rev Mol Cell Biol (2012) 13:607-25. doi:10.1038/nrm3440.
54. Rapizzi E, Pinton P, Szabadkai G, Wieckowski MR, Vandecasteele G, Baird G, et al. Recombinant expression of the voltage-dependent anion channel enhances the transfer of Ca2+ microdomains to mitochondria. J Cell Biol (2002) 159:613-24. doi:10.1083/jcb.200205091.
55. De Stefani D, Bononi A, Romagnoli A, Messina A, De Pinto V, Pinton P, et al. VDAC1 selectively transfers apoptotic Ca2+ signals to mitochondria. Cell Death Differ (2012) 19:267-73. doi:10.1038/cdd.2011.92.
56. Grills C, Jithesh PV, Blayney J, Zhang SD, Fennell DA. Gene expression meta-analysis identifies VDAC1 as a predictor of poor outcome in early stage non-small cell lung cancer. PLoS One (2011) 6:e14635. doi:10.1371/journal.pone.0014635.
57. Wolf A, Agnihotri S, Micallef J, Mukherjee J, Sabha N, Cairns R, et al. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med (2011) 208:313-26. doi:10.1084/jem.20101470.
58. Shoshan-Barmatz V, Golan M. Mitochondrial VDAC1: function in cell life and death and a target for cancer therapy. Curr Med Chem (2012) 19:714-35. doi:10.2174/092986712798992110.
59. Pastorino JG, Shulga N, Hoek JB. Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem (2002) 277:7610-8. doi:10.1074/jbc.M109950200.
60. Marchi S, Pinton P. The mitochondrial calcium uniporter complex: molecular components, structure and physiopathological implications. J Physiol (2014) 592:829-39. doi:10.1113/jphysiol.2013.268235.
61. Marchi S, Lupini L, Patergnani S, Rimessi A, Missiroli S, Bonora M, et al. Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25. Curr Biol (2013) 23:58-63. doi:10.1016/j.cub.2012.11.026.
62. Csordas G, Hajnoczky G. SR/ER-mitochondrial local communication: calcium and ROS. Biochim Biophys Acta (2009) 1787:1352-62. doi:10.1016/j.bbabio.2009.06.004.
63. Marchi S, Giorgi C, Suski JM, Agnoletto C, Bononi A, Bonora M, et al. Mitochondria-ros crosstalk in the control of cell death and aging. J Signal Transduct (2012) 2012:329635. doi:10.1155/2012/329635.
64. Schumacker PT. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell (2006) 10:175-6. doi:10.1016/j.ccr.2006.08.015.
65. Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell (2012) 48:158-67. doi:10.1016/j.molcel.2012.09.025.
66. Hamanaka RB, Chandel NS. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem Sci (2010) 35:505-13. doi:10.1016/j.tibs.2010.04.002.
67. Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer (2003) 3:459-65. doi:10.1038/nrc1097.
68. Bivona TG, Quatela SE, Bodemann BO, Ahearn IM, Soskis MJ, Mor A, et al. PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis. Mol Cell (2006) 21:481-93. doi:10.1016/j.molcel.2006.01.012.
69. Gough DJ, Corlett A, Schlessinger K, Wegrzyn J, Larner AC, Levy DE. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science (2009) 324:1713-6. doi:10.1126/science.1171721.
70. Hu Y, Lu W, Chen G, Wang P, Chen Z, Zhou Y, et al. K-ras(G12V) transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis. Cell Res (2012) 22:399-412. doi:10.1038/cr.2011.145.
71. Rimessi A, Marchi S, Patergnani S, Pinton P. H-Ras-driven tumoral maintenance is sustained through caveolin-1-dependent alterations in calcium signaling. Oncogene (2014) 33:2329-40. doi:10.1038/onc.2013.192.
72. Viale A, Pettazzoni P, Lyssiotis CA, Ying H, Sanchez N, Marchesini M, et al. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature (2014) 514:628-32. doi:10.1038/nature13611.
73. Samudio I, Harmancey R, Fiegl M, Kantarjian H, Konopleva M, Korchin B, et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J Clin Invest (2010) 120:142-56. doi:10.1172/JCI38942.
74. Skrtic M, Sriskanthadevan S, Jhas B, Gebbia M, Wang X, Wang Z, et al. Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell (2011) 20:674-88. doi:10.1016/j.ccr.2011.10.015.
75. Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M, et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell (2013) 12:329-41. doi:10.1016/j.stem.2012.12.013.
76. Bijur GN, Jope RS. Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J Neurochem (2003) 87:1427-35. doi:10.1046/j.1471-4159.2003.02113.x.
77. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev (2001) 15:1406-18. doi:10.1101/gad.889901.
78. Majewski N, Nogueira V, Bhaskar P, Coy PE, Skeen JE, Gottlob K, et al. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell (2004) 16:819-30. doi:10.1016/j.molcel.2004.11.014.
79. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell (2007) 129:1261-74. doi:10.1016/j.cell.2007.06.009.
80. Marchi S, Rimessi A, Giorgi C, Baldini C, Ferroni L, Rizzuto R, et al. Akt kinase reducing endoplasmic reticulum Ca2+ release protects cells from Ca2+-dependent apoptotic stimuli. Biochem Biophys Res Commun (2008) 375:501-5. doi:10.1016/j.bbrc.2008.07.153.
81. Marchi S, Marinello M, Bononi A, Bonora M, Giorgi C, Rimessi A, et al. Selective modulation of subtype III IP(3)R by Akt regulates ER Ca(2)(+) release and apoptosis. Cell Death Dis (2012) 3:e304. doi:10.1038/cddis.2012.45.
82. Salmena L, Carracedo A, Pandolfi PP. Tenets of PTEN tumor suppression. Cell (2008) 133:403-14. doi:10.1016/j.cell.2008.04.013.
83. Bononi A, Bonora M, Marchi S, Missiroli S, Poletti F, Giorgi C, et al. Identification of PTEN at the ER and MAMs and its regulation of Ca(2+) signaling and apoptosis in a protein phosphatase-dependent manner. Cell Death Differ (2013) 20:1631-43. doi:10.1038/cdd.2013.77.
84. Rabellino A, Carter B, Konstantinidou G, Wu SY, Rimessi A, Byers LA, et al. The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA. Cancer Res (2012) 72:2275-84. doi:10.1158/0008-5472.CAN-11-3159.
85. Giorgi C, Ito K, Lin HK, Santangelo C, Wieckowski MR, Lebiedzinska M, et al. PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science (2010) 330:1247-51. doi:10.1126/science.1189157.
86. Hedgepeth SC, Garcia MI, Wagner LE II, Rodriguez AM, Chintapalli SV, Snyder RR, et al. The BRCA1 tumor suppressor binds to inositol 1,4,5-trisphosphate receptors to stimulate apoptotic calcium release. J Biol Chem (2015) 290:7304-13. doi:10.1074/jbc.M114.611186.
87. Moll UM, Wolff S, Speidel D, Deppert W. Transcription-independent pro-apoptotic functions of p53. Curr Opin Cell Biol (2005) 17:631-6. doi:10.1016/j.ceb.2005.09.007.
88. Green DR, Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature (2009) 458:1127-30. doi:10.1038/nature07986.
89. Giorgi C, Bonora M, Missiroli S, Poletti F, Ramirez FG, Morciano G, et al. Intravital imaging reveals p53-dependent cancer cell death induced by phototherapy via calcium signaling. Oncotarget (2015) 6:1435-45.
90. Giorgi C, Bonora M, Sorrentino G, Missiroli S, Poletti F, Suski JM, et al. p53 at the endoplasmic reticulum regulates apoptosis in a Ca2+-dependent manner. Proc Natl Acad Sci U S A (2015) 112:1779-84. doi:10.1073/pnas.1410723112.
91. Rimessi A, Marchi S, Fotino C, Romagnoli A, Huebner K, Croce CM, et al. Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosis. Proc Natl Acad Sci U S A (2009) 106:12753-8. doi:10.1073/pnas.0906484106.
92. Griffin C, Karnik A, McNulty J, Pandey S. Pancratistatin selectively targets cancer cell mitochondria and reduces growth of human colon tumor xenografts. Mol Cancer Ther (2011) 10:57-68. doi:10.1158/1535-7163.MCT-10-0735.
93. Bernal SD, Lampidis TJ, Summerhayes IC, Chen LB. Rhodamine-123 selectively reduces clonal growth of carcinoma cells in vitro. Science (1982) 218:1117-9. doi:10.1126/science.7146897.
94. Summerhayes IC, Lampidis TJ, Bernal SD, Nadakavukaren JJ, Nadakavukaren KK, Shepherd EL, et al. Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. Proc Natl Acad Sci U S A (1982) 79:5292-6. doi:10.1073/pnas.79.17.5292.
95. Capozzi A, Mantuano E, Matarrese P, Saccomanni G, Manera C, Mattei V, et al. A new 4-phenyl-1,8-naphthyridine derivative affects carcinoma cell proliferation by impairing cell cycle progression and inducing apoptosis. Anticancer Agents Med Chem (2012) 12:653-62. doi:10.2174/187152012800617731.
96. Broadley K, Larsen L, Herst PM, Smith RA, Berridge MV, McConnell MJ. The novel phloroglucinol PMT7 kills glycolytic cancer cells by blocking autophagy and sensitizing to nutrient stress. J Cell Biochem (2011) 112:1869-79. doi:10.1002/jcb.23107.
97. Mollinedo F, Fernandez M, Hornillos V, Delgado J, Amat-Guerri F, Acuna AU, et al. Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria. Cell Death Dis (2011) 2:e158. doi:10.1038/cddis.2011.41.
98. Wen S, Zhu D, Huang P. Targeting cancer cell mitochondria as a therapeutic approach. Future Med Chem (2013) 5:53-67. doi:10.4155/fmc.12.190.
99. Hou H, Sun H, Lu P, Ge C, Zhang L, Li H, et al. Tunicamycin potentiates cisplatin anticancer efficacy through the DPAGT1/Akt/ABCG2 pathway in mouse Xenograft models of human hepatocellular carcinoma. Mol Cancer Ther (2013) 12:2874-84. doi:10.1158/1535-7163.MCT-13-0201.
100. Carracedo A, Gironella M, Lorente M, Garcia S, Guzman M, Velasco G, et al. Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res (2006) 66:6748-55. doi:10.1158/0008-5472.CAN-06-0169.
101. Verfaillie T, Rubio N, Garg AD, Bultynck G, Rizzuto R, Decuypere JP, et al. PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress. Cell Death Differ (2012) 19:1880-91. doi:10.1038/cdd.2012.74.
102. Shao RG, Shimizu T, Pommier Y. Brefeldin A is a potent inducer of apoptosis in human cancer cells independently of p53. Exp Cell Res (1996) 227:190-6. doi:10.1006/excr.1996.0266.
103. Landowski TH, Megli CJ, Nullmeyer KD, Lynch RM, Dorr RT. Mitochondrial-mediated dysregulation of Ca2+ is a critical determinant of Velcade (PS-341/bortezomib) cytotoxicity in myeloma cell lines. Cancer Res (2005) 65:3828-36. doi:10.1158/0008-5472.CAN-04-3684.
104. Chen R, Valencia I, Zhong F, McColl KS, Roderick HL, Bootman MD, et al. Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate. J Cell Biol (2004) 166:193-203. doi:10.1083/jcb.200309146.
105. Rong YP, Aromolaran AS, Bultynck G, Zhong F, Li X, McColl K, et al. Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals. Mol Cell (2008) 31:255-65. doi:10.1016/j.molcel.2008.06.014.
106. Ni Chonghaile T, Sarosiek KA, Vo TT, Ryan JA, Tammareddi A, Moore Vdel G, et al. Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science (2011) 334:1129-33. doi:10.1126/science.1206727.
107. Zhong F, Harr MW, Bultynck G, Monaco G, Parys JB, De Smedt H, et al. Induction of Ca(2)+-driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2-IP3 receptor interaction. Blood (2011) 117:2924-34. doi:10.1182/blood-2010-09-307405.
108. Akl H, Monaco G, La Rovere R, Welkenhuyzen K, Kiviluoto S, Vervliet T, et al. IP3R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP3R-derived peptide targeting the BH4 domain of Bcl-2. Cell Death Dis (2013) 4:e632. doi:10.1038/cddis.2013.140.
109. Yagoda N, Von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ, et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature (2007) 447:864-8. doi:10.1038/nature05859.
110. Cardaci S, Ciriolo MR. TCA cycle defects and cancer: when metabolism tunes redox state. Int J Cell Biol (2012) 2012:161837. doi:10.1155/2012/161837.
111. Penso J, Beitner R. Clotrimazole and bifonazole detach hexokinase from mitochondria of melanoma cells. Eur J Pharmacol (1998) 342:113-7. doi:10.1016/S0014-2999(97)01507-0.
112. Mathupala SP, Ko YH, Pedersen PL. Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene (2006) 25:4777-86. doi:10.1038/sj.onc.1209603.
113. Simamura E, Hirai K, Shimada H, Koyama J, Niwa Y, Shimizu S. Furanonaphthoquinones cause apoptosis of cancer cells by inducing the production of reactive oxygen species by the mitochondrial voltage-dependent anion channel. Cancer Biol Ther (2006) 5:1523-9. doi:10.4161/cbt.5.11.3302.
114. Hayes J, Peruzzi PP, Lawler S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med (2014) 20:460-9. doi:10.1016/j.molmed.2014.06.005.
115. Tan AS, Baty JW, Dong LF, Bezawork-Geleta A, Endaya B, Goodwin J, et al. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. Cell Metab (2015) 21:81-94. doi:10.1016/j.cmet.2014.12.003.